Alterity Therapeutics (PRNAD) Tax Provisions (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Tax Provisions for 15 consecutive years, with $5.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Tax Provisions rose 37.9% year-over-year to $5.2 million; the TTM figure through Dec 2025 stood at $18.2 million (up 1.61% YoY), while the FY2025 annual figure was $43584.7, down 100.0% from the prior year.
• Tax Provisions came in at $5.2 million for Q4 2025 at Alterity Therapeutics, up from $3.8 million in the prior quarter.
• The five-year high for Tax Provisions was $5.2 million in Q4 2025, with the low at $3.8 million in Q4 2024.
• Average Tax Provisions over 5 years is $4.6 million, with a median of $4.9 million recorded in 2021.
• Across the five-year window, Tax Provisions declined 18.82% in 2023 and jumped 37.9% in 2025, its largest moves.
• Year by year, Tax Provisions stood at $4.9 million in 2021, then advanced by 3.56% to $5.1 million in 2022, then slipped by 18.82% to $4.1 million in 2023, then declined by 8.7% to $3.8 million in 2024, then jumped by 37.9% to $5.2 million in 2025.
• According to Business Quant data, Tax Provisions over the past three periods registered $5.2 million, $3.8 million, and $4.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.